You are here:

Pregabalin (Lyrica®)


Following a full submission.

Pregabalin (Lyrica®) is accepted for restricted use within NHS Scotland as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

It should be initiated only by physicians who have appropriate experience in the treatment of epilepsy and should be used principally in patients who have not benefited from treatment with an older anti-convulsant drug such as carbamazepine or sodium valproate, or for whom these drugs are unsuitable because of contra-indications, interaction or poor tolerance.

Drug Details

Drug Name: Pregabalin (Lyrica®)
SMC Drug ID: 145/04
Manufacturer: Pfizer Ltd
Indication: Epilepsy
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Full submission
Status: Restricted
Date Advice Published: 10 January 2005